Cargando…
CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1
CRISPR editing of retroviral proviruses has been limited to HIV-1. We propose human T-cell leukemia virus type 1 (HTLV-1) as an excellent model to advance CRISPR/Cas9 genome editing technologies against actively expressing and latent retroviral proviruses. HTLV-1 is a tumorigenic human retrovirus re...
Autores principales: | Panfil, Amanda R., Green, Patrick L., Yoder, Kristine E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785941/ https://www.ncbi.nlm.nih.gov/pubmed/33425776 http://dx.doi.org/10.3389/fcimb.2020.580371 |
Ejemplares similares
-
CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
por: Panfil, Amanda R., et al.
Publicado: (2018) -
Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection
por: Maslennikova, Alexandra, et al.
Publicado: (2022) -
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019) -
Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2
por: Lin, Edward, et al.
Publicado: (2022) -
Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing
por: Sharma, Rohit, et al.
Publicado: (2022)